Search

everythinglearnresearchcommunity

for

Search:↓

Women with hair thinning have disrupted steroid hormone levels, but this doesn't often show as other health issues. More research is needed on hormone balance in this condition.

A new gene, JMJD1C, may affect testosterone levels in men.

Obesity changes androgen levels in women with PCOS, leading to higher testosterone relative to androstenedione.

PSA can help diagnose high androgen levels in women.

Flutamide combined with a low-dose birth control pill effectively reduces excessive hair growth in women with polycystic ovarian disease.

Blocking CRF1 receptors improved male hormone levels and reduced testicular tumor size in men with a specific adrenal condition.

The new oral testosterone pill normalized testosterone levels and lowered SHBG in men with low testosterone.

Certain SHBG gene variants, like rs727428, are linked to higher testosterone levels in women with PCOS.

SHBG may be a useful early indicator and treatment target for PCOS.

Certain genetic variations in the SHBG gene are linked to an increased or decreased risk of PCOS in Mediterranean women.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

Certain changes in the SHBG gene may increase the risk of PCOS in Iraqi women.

Premature balding in some men may be linked to altered hormones, but it's not the male equivalent to polycystic ovary syndrome or metabolic syndrome.

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

SHBG binding properties are unchanged in male liver cirrhosis patients.

Women with female-pattern baldness produce more testosterone, but 5a-reductase inhibition treatment won't help.

Lower SHBG levels may increase the risk of PCOS.

Women with PCOS have fewer activated T cells in their ovarian follicles, which might affect fertility.

Low SHBG and high FAI, FT, and DHEAS levels are effective in identifying PCOS.

Men with hair loss have lower SHBG and higher saliva testosterone levels, suggesting increased androgen activity.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

Young women with diffuse hair loss may have low SHBG levels, which could lead to more active testosterone and contribute to their hair loss.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.

The estradiol valerate/dienogest oral contraceptive helps with heavy periods, may improve acne and symptoms in PCOS, and doesn't affect sexual function.

Topical spironolactone cream doesn't cause hormone-related side effects in the body.

Postmenopausal women with hyperandrogenism didn't have better metabolic health even after their testosterone levels became normal.

Mild thyroid issues don't affect the metabolism and hormones of women with PCOS.

Weight loss and metformin don't significantly change vaspin levels in women with PCOS.

Dutasteride and finasteride may reduce sperm count and volume but don't affect movement or shape; effects are reversible after stopping.